Korean Journal of Clinical Laboratory Science (대한임상검사과학회지)

Korean Society for Clinical Laboratory Science (대한임상검사과학회)
권호 표지
DOI QR코드

DOI QR Code

MicroRNA-126 Regulates the Expression of Stem Cell Transcription Factors (Sox2 and Lin28) in Various Ovarian Tumors

MicroRNA-126은 난소 종양세포의 줄기세포 전사인자 (Sox2와 Lin28) 발현을 조절한다

  • Park, Ho (Department of Clinical Laboratory Science, Wonkwang Health Science University) ;
  • Jekal, Seung Joo (Department of Clinical Laboratory Science, Wonkwang Health Science University)
  • 박호 (원광보건대학교 임상병리과) ;
  • 제갈승주 (원광보건대학교 임상병리과)
  • Received : 2015.11.01
  • Accepted : 2015.11.26
  • Published : 2015.12.30
Download PDF
⟨ Previous Next ⟩

Abstract

Stem cell-like tumor cells are reported to be the main reason for tumor recurrence and metastasis. As one of the new approaches to overcome cancer, studies are emerging to inhibit the expressions of stem cell transcriptional factors (Oct4, Sox2, Klf-4, and Lin28) in cancer cells. MicroRNAs are master genetic regulators that can control development and differentiation of stem cells. In this study using various ovarian tumors (Skov3, Ovcar3, Tov112D, Tov21G, PA-1 and Hsc832(c)T), we examined the expressions of stem cell-related transcription factors, and the biological changes in cell survival and growth by miR-126 that targets stem cell transcriptional factors. We observed that treatment of miR-126 induced the morphological changes and cell suspension in most cells. In addition, miR-126 induced gradual regression of cell division except Skov3 cells, especially significant time-dependent reduction in Tov112D, Tov21G and PA-1. When we examined the expression of stem cell transcriptional factors, Sox2 was shown to be down-regulated after miR-126. Our results demonstrate that miR-126 treatment can provide the reversible environment to regulate cell division and to induce cell death of ovarian tumors, suggesting the molecular biological clues for clinical usage.

최근 종양을 극복하고자 하는 새로운 접근 방법가운데 하나로, 종양세포내에 발현되는 줄기세포 전사인자들(Oct4, Sox2, KLF4 and Lin28)을 억제하여 종양을 치료하는 연구들이 증가하고 있다. 본 실험은 미분화 전사인자를 표적(조절)하는 microRNA-126을 이용하여 난소종양세포들(6종: HSC832(t)c, Ovcar3, Skov3, PA-1, TOV21G and Tov112D)들 생존과 성장에 어떠한 생물학적 변화를 유도하는지 연구하였다. Scramble과 microRNA-126를 난소종양세포들에 처리 후 세포모양 관찰결과 Skov3를 제외한 난소 종양세포들에서 형태학적 모양 변성과 부유현상을 관찰하였다. CCK-8을 이용한 세포분열능 분석에서 Skov3를 제외한 난소 종양세포들의 분열능력이 점차적으로 감소되는 것을 확인하였다. 특히 Tov112D, Tov21G and PA-1에서 각 시간대별로 뚜렷한 세포분열 능력 감소를 확인할 수 있었다. RT-PCR결과 미분화 전사인자들(Sox2, Lin28)의 발현감소를 확인할 수 있었다. 이러한 결과들은 microRNA-126이 다양한 난소 종양세포들을 표적하여 세포분열능과 사멸을 유도할 수 있는 가역적 환경(유전자 발현조절)을 제공함과 동시에 임상 치료에 대한 분자생물학적 단서를 제공할 수 있을 것이다.

Keywords

References

  1. Adachi K, Nikaido I, Ohta H, Ohtsuka S, Ura H, Kadota M, et al. Context-dependent wiring of Sox2 regulatory networks for self-renewal of embryonic and trophoblast stem cells. Mol Cell. 2013, 52(3): 380-392. https://doi.org/10.1016/j.molcel.2013.09.002
  2. Ann Pietrangelo, Brenda B. Spriggs. The outlook for ovarian cancer: prognosis, life expectancy & survival rates by stage. http://www.healthline.com/health/cancer/ovarian-cancer- outlook#Overview1, last visited on 2015, November 19.
  3. Becker KA, Ghule PN, Therrien JA, Lian JB, Stein JL, van Wijnen AJ, et al. Self-renewal of human embryonic stem cells is supported by a shortened G1 cell cycle phase. Journal of cellular physiology. 2006, 209(3):883-893. https://doi.org/10.1002/jcp.20776
  4. Chien CS, Wang ML, Chu PY, Chang YL, Liu WH, Yu CC, et al. Lin28B/Let-7 regulates expression of Oct4 and Sox2 and reprograms oral squamous cell carcinoma cells to a stem-like state. Cancer Res. 2015, 75(21):2553-2565. https://doi.org/10.1158/0008-5472.CAN-14-2215
  5. Cimadamore F, Amador-Arjona A, Chen C, Huang CT, Terskikh AV. Sox2-Lin28/let-7 pathway regulates proliferation and neurogenesis in neural precursors. Proc Natl Acad Sci. 2013, 110(32):E3017-E30-26. https://doi.org/10.1073/pnas.1220176110
  6. Crawford M, Brawner E, Batte K, Yu L, Hunter MG, Otterson GA, et al. MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines. Biochem Biophys Res Commun. 2008, 373(4):607-612. https://doi.org/10.1016/j.bbrc.2008.06.090
  7. Eulalio A, Huntzinger E, Nishihara T, Rehwinkel J, Fauser M, Izaurralde E. Deadenylation is a widespread effect of miRNA regulation. RNA. 2009, 15(1):21-32.
  8. Hamano R, Miyata H, Yamasaki M, Sugimura K, Tanaka K, Kurokawa Y, et al. High expression of Lin28 is associated with tumour aggressiveness and poor prognosis of patients in oesophagus cancer. Br J Cancer. 2012, 106(8):1415-1423. https://doi.org/10.1038/bjc.2012.90
  9. Ittai BP, Matthew WT, Vincent JC, Ruping G, George WB, Aviv R, et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nature Genetics. 2008, 40:499-507. https://doi.org/10.1038/ng.127
  10. Li XM, Wang AM, Zhang J, Yi H. Down-regulation of micro-RNA-126 expression in colorectal cancer and its clinical significance. Med Oncol. 2011, 28(4):1054-1057. https://doi.org/10.1007/s12032-010-9637-6
  11. Li Y, Chen K, Li L, Li R, Zhang J, Ren W. Overexpression of Sox2 is involved in paclitaxel resistance of ovarian cancer via the PI3K/Akt pathway. Tumour Biol. 2015, 11:1-6.
  12. Lin F, Lin P, Zhao D, Chen Y, Xiao L, Qin W, et al. Sox2 targets cyclinE, p27 and survivin to regulate androgen-independent human prostate cancer cell proliferation and apoptosis. Cell Prolif. 2012, 45(3):207-216. https://doi.org/10.1111/j.1365-2184.2012.00812.x
  13. Liu B, Peng XC, Zheng XL, Wang J, Qin YW. MicroRNA-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo. Lung Cancer. 2009, 66(2):169-175. https://doi.org/10.1016/j.lungcan.2009.01.010
  14. Liu LY, Wang W, Zhao LY, Guo B, Yang J, Zhao XG, et al. MicroRNA-126 inhibits growth of SGC-7901 cells by synergistically targeting the oncogenes PI3KR2 and Crk, and the tumor suppressor PLK2. Int J Oncol. 2014, 45(3):1257-1265. https://doi.org/10.3892/ijo.2014.2516
  15. Luo P, Fei J, Zhou J, Zhang W. microRNA-126 suppresses PAK4 expression in ovarian cancer SKOV3 cells. Oncol Lett. 2015, 9(5):2225-2229. https://doi.org/10.3892/ol.2015.3012
  16. Ma W, Ma J, Xu J, Qiao C, Branscum A, Cardenas A, et al. Lin28 regulates BMP4 and functions with Oct4 to affect ovarian tumor microenvironment. Cell Cycle. 2013, 12(1):88-97. https://doi.org/10.4161/cc.23028
  17. McLean K, Gong Y, Choi Y, Deng N, Yang K, Bai S, et al. Human ovarian carcinoma-associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production. J Clin Invest. 2011, 121(8):3206-3219. https://doi.org/10.1172/JCI45273
  18. Nguyen LV, Vanner R, Dirks P, Eaves CJ. Cancer stem cells: an evolving concept. Nat Rev Cancer. 2012, 12:133-143. https://doi.org/10.1038/nrc3184
  19. Otsubo T, Akiyama Y, Hashimoto Y, Shimada S, Goto K, Yuasa Y. MicroRNA-126 inhibits Sox2 expression and contributes to gastric carcinogenesis. PLoS One. 2011, 6(1):e16617. https://doi.org/10.1371/journal.pone.0016617
  20. Peng S, Maihle NJ, Huang Y. Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer. Oncogene. 2010, 29(14):2153-2159. https://doi.org/10.1038/onc.2009.500
  21. Park CE, Hong SN. Expression patterns of cell cycle related genes mRNA and proteins in the mouse ovary. Korean J Clin Lab Sci. 2006, 38:72-81.
  22. Park CE, Kim DJ, Hong SN. Expression of mRNAs and proteins of cyclin A and LATS genes in ovary. Korean J Clin Lab Sci. 2008, 40:31-40.
  23. Saito Y, Friedman JM, Chihara Y, Egger G, Chuang JC, Liang G. Epigenetic therapy upregulates the tumor suppressor micro-RNA-126 and its host gene EGFL7 in human cancer cells. Biochem Biophys Res Commun. 2009, 379(3):726-731. https://doi.org/10.1016/j.bbrc.2008.12.098
  24. Sales KM, Winslet MC, Seifalian AM. Stem cells and cancer: an overview. Stem Cell Rev. 2007, 3(4): 249-255. https://doi.org/10.1007/s12015-007-9002-0
  25. Schoenhals M, Kassambara A, De Vos J, Hose D, Moreaux J, Klein B. Embryonic stem cell markers expression in cancers. Biochem Biophys Res Commun. 2009, 383(2):157-162. https://doi.org/10.1016/j.bbrc.2009.02.156
  26. Shen WF, Hu YL, Uttarwar L, Passegue E, Largman C. Micro-RNA-126 regulates HOXA9 by binding to the homeobox. Mol Cell Biol. 2008, 28(14):4609-4619. https://doi.org/10.1128/MCB.01652-07
  27. Sun Y, Bai Y, Zhang F, Wang Y, Guo Y, Guo L. microRNA-126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7. Biochem Biophys Res Commun. 2010, 391(3):1483-1489. https://doi.org/10.1016/j.bbrc.2009.12.098
  28. Viswanathan SR, Powers JT, Einhorn W, Hoshida Y, Ng TL, Toffanin S, et al. Lin28 promotes transformation and is associated with advanced human malignancies. Nat Genet 2009, 41: 843-848. https://doi.org/10.1038/ng.392
  29. Williams AE. Functional aspects of animal microRNAs. Cell. Mol. Life Sci. 2008, 65(4):545-562. https://doi.org/10.1007/s00018-007-7355-9
  30. Xu B, Zhang K, Huang Y. Lin28 modulates cell growth and associates with a subset of cell cycle regulator mRNAs in mouse embryonic stem cells. RNA. 2009, 15:357-361. https://doi.org/10.1261/rna.1368009
  31. Zhang J, Du YY, Lin YF, Chen YT, Yang L, Wang HJ, et al. The cell growth suppressor, microRNA-126, targets IRS-1. Biochem Biophys Res Commun. 2008, 377(1):136-140. https://doi.org/10.1016/j.bbrc.2008.09.089
  32. Zhang Q, Zeng S, Quan C, Lin X. Induction function of microRNA-126 in survival and proliferation in neural stem cells. Med Sci Monit. 2015, 21:3023-3027. https://doi.org/10.12659/MSM.894672